Loading candles…
Aarti Drugs Ltd., incorporated in 1984, operates in the pharmaceuticals and specialty chemicals industries. The company manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and finished dosage formulations. It follows a vertically integrated business model and exports its APIs and specialty chemicals to over 100 countries across six continents. Aarti Drugs Ltd. includes Pinnacle Life Science Private Limited, its wholly-owned subsidiary focused on finished dosage formulations. The company holds leadership positions in therapeutic categories such as anti-protozoals and anti-inflammatory drugs. As part of the Aarti Group of Industries, valued at $1 billion, Aarti Drugs Ltd. has grown into a global leader for several high-volume molecules.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 15 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and Interim dividend for FY 2025-26, if any | 3 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 7 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 18 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 6 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.